Locatelli, Franco
 Distribuzione geografica
Continente #
AS - Asia 34.077
NA - Nord America 22.463
EU - Europa 8.989
SA - Sud America 6.735
Continente sconosciuto - Info sul continente non disponibili 1.546
AF - Africa 744
OC - Oceania 38
AN - Antartide 1
Totale 74.593
Nazione #
US - Stati Uniti d'America 21.338
SG - Singapore 16.392
CN - Cina 7.999
BR - Brasile 5.564
IT - Italia 2.366
VN - Vietnam 2.011
FR - Francia 1.387
ID - Indonesia 1.323
IE - Irlanda 1.212
KR - Corea 1.015
BD - Bangladesh 983
IN - India 951
DE - Germania 933
JP - Giappone 883
RU - Federazione Russa 787
HK - Hong Kong 765
GB - Regno Unito 550
AR - Argentina 467
CA - Canada 452
IQ - Iraq 372
SE - Svezia 369
MX - Messico 318
FI - Finlandia 254
ZA - Sudafrica 214
NL - Olanda 194
TR - Turchia 178
PK - Pakistan 159
AT - Austria 155
VE - Venezuela 154
EC - Ecuador 151
UA - Ucraina 142
PL - Polonia 134
SA - Arabia Saudita 129
ES - Italia 116
MA - Marocco 114
CO - Colombia 112
UZ - Uzbekistan 100
CZ - Repubblica Ceca 93
JO - Giordania 89
PH - Filippine 88
CL - Cile 79
JM - Giamaica 77
KE - Kenya 77
PY - Paraguay 74
NP - Nepal 69
EG - Egitto 66
MY - Malesia 62
TH - Thailandia 59
AZ - Azerbaigian 54
AE - Emirati Arabi Uniti 52
CR - Costa Rica 51
DZ - Algeria 51
PE - Perù 50
UY - Uruguay 49
CH - Svizzera 45
TN - Tunisia 44
ET - Etiopia 42
KZ - Kazakistan 42
IL - Israele 40
OM - Oman 40
LB - Libano 34
HN - Honduras 33
TT - Trinidad e Tobago 32
IR - Iran 31
AU - Australia 30
PT - Portogallo 30
BO - Bolivia 29
DO - Repubblica Dominicana 27
SN - Senegal 26
BG - Bulgaria 23
BH - Bahrain 23
BB - Barbados 22
BE - Belgio 22
NG - Nigeria 22
PA - Panama 22
SY - Repubblica araba siriana 21
GT - Guatemala 19
RO - Romania 19
AL - Albania 18
LT - Lituania 18
NI - Nicaragua 18
BY - Bielorussia 17
MD - Moldavia 17
PS - Palestinian Territory 17
CI - Costa d'Avorio 16
GE - Georgia 15
RS - Serbia 14
KG - Kirghizistan 13
SK - Slovacchia (Repubblica Slovacca) 12
SV - El Salvador 12
LV - Lettonia 10
CG - Congo 9
DK - Danimarca 9
HU - Ungheria 9
KW - Kuwait 9
AM - Armenia 8
AO - Angola 8
GA - Gabon 8
MM - Myanmar 8
BS - Bahamas 7
Totale 72.873
Città #
Singapore 7.978
San Jose 4.141
Ashburn 4.040
Hefei 2.977
Jakarta 1.282
Dublin 1.207
Lauterbourg 1.046
Seoul 995
Los Angeles 893
Kent 879
Tokyo 860
Hong Kong 708
Ho Chi Minh City 700
New York 629
Beijing 599
Milan 540
Moscow 534
Hyderabad 488
Dallas 487
Hanoi 471
São Paulo 468
Santa Clara 401
Boardman 344
Rome 331
Frankfurt am Main 328
Buffalo 325
Council Bluffs 297
Chicago 284
Washington 282
Nuremberg 267
Brooklyn 166
Rio de Janeiro 165
St Louis 160
Atlanta 143
Helsinki 132
Paris 126
San Francisco 123
Baghdad 120
London 119
Seattle 119
Shanghai 119
Phoenix 118
Toronto 115
Belo Horizonte 113
Chandler 112
Johannesburg 106
Brasília 105
Munich 104
Mexico City 96
Curitiba 95
Dhaka 95
Warsaw 92
Da Nang 88
Montreal 87
Memphis 85
Amman 83
Porto Alegre 83
Haiphong 82
Brno 81
Orem 81
Tashkent 80
Boston 78
Houston 76
Campinas 75
Nairobi 73
Charlotte 71
Lappeenranta 71
Bologna 68
Arezzo 64
Pune 64
Guayaquil 62
Philadelphia 61
Amsterdam 60
Jacksonville 59
Vienna 58
Bangkok 55
Chennai 54
The Dalles 54
Erbil 53
Denver 51
Quito 51
Las Vegas 49
Baku 48
Buenos Aires 48
Florence 48
Guarulhos 48
Istanbul 48
Naples 48
Ribeirão Preto 47
Cape Town 46
Kingston 46
Guangzhou 45
Montevideo 45
Salvador 44
Goiânia 43
Caracas 42
Lahore 42
Mumbai 42
Riyadh 42
Miami 41
Totale 40.294
Nome #
Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia 546
Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia 526
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease 260
Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism 254
Occurrence of long-term effects after hematopoietic stem cell transplantation in children affected by acute leukemia receiving either busulfan or total body irradiation: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study 244
Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms 240
Functional depletion of T cells by vincristine and methylprednisolone as an in vitro model for the prevention of graft versus host disease 238
Mutations in CBL occur frequently in juvenile myelomonocytic leukemia 223
High-dose vincristine, fractionated total-body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission: a 7-year Italian multicentre study 222
Advancements and challenges in CAR T cell therapy in autoimmune diseases 216
Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry 215
Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients 204
Cyclosporine-A as GVHD prophylaxis in allogeneic BMT for childhood acute leukemia. AIEOP-BMT group 199
Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients 199
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma 189
High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre study 176
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma. Reply 173
Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients 170
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party 163
Biological, functional and genetic characterization of bone marrow-derived mesenchymal stromal cells from pediatric patients affected by acute lymphoblastic leukemia 155
Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells 154
Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study 144
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma 142
Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy 133
Proteomics study of peripheral blood mononuclear cells in down syndrome children 132
Inhibition of natural killer cell cytotoxicity by interleukin-6: Implications for the pathogenesis of macrophage activation syndrome 131
Achievement of operational tolerance in a pediatric liver transplant recipient following successful hematopoietic stem cell transplantation from a different donor 128
Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study 128
Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party 123
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma 123
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia 122
Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in beta-thalassemia 121
AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity 121
Thymic Function and T-Cell Receptor Repertoire Diversity: Implications for Patient Response to Checkpoint Blockade Immunotherapy 118
KRAS and CREBBP mutations: A relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia 118
CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia 117
Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial 117
Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia 116
How I treat relapsed childhood acute lymphoblastic leukemia 116
Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma 116
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study 115
Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP) 113
Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS 113
Does the emergence and persistence of donor-derived leukaemia-reactive cytotoxic T lymphocytes protect patients given an allogeneic BMT from recurrence? Results of a preliminary study 107
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant 105
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient 104
Usefulness of 18F-FDG PET/CT in an Unusual Case of Solid-Pseudopapillary Pancreatic Tumor in Childhood With Aggressive Behavior 104
First experience of combined enzyme replacement therapy and hematopoietic stem cell transplantation in alpha-mannosidosis 101
Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties 101
Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: An I-BFM Study Group collaboration 101
Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response 101
MicroRNAs-Proteomic Networks Characterizing Human Medulloblastoma-SLCs 101
Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia 101
Exagamglogene Autotemcel for Severe Sickle Cell Disease 100
Recommendations on the use of colony-stimulating factors in children: conclusions of a European panel 100
Identification of a new HLA-B*44 allele, HLA-B*44:02:68, by next generation sequencing 98
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results 96
Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato-Oncologia Pediatrica 95
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL 95
Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches 94
Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells 94
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient 94
Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing 93
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study 93
The role of allogeneic hematopoietic stem cell transplantation in pediatric leukemia 92
Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications 92
T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies 92
EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD 92
Outcome of children with acute leukemia given HLA-haploidentical HSCT after ab T-cell and B-cell depletion 91
Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS 91
Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience 90
The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx) 90
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 89
Killer Ig-like receptors (KIRs): Their role in NK cell modulation and developments leading to their clinical exploitation 89
Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: report of 20 novel mutations 88
The role of interferon-gamma and its signaling pathway in pediatric hematological disorders 88
Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia 88
Engineered mucoperiosteal scaffold for cleft palate regeneration towards the non-immunogenic transplantation 88
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease 88
A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients 87
Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors 87
Decellularized esophageal tubular scaffold microperforated by quantum molecular resonance technology and seeded with mesenchymal stromal cells for tissue engineering esophageal regeneration 87
TFG binds LC3C to regulate ULK1 localization and autophagosome formation 87
Donor natural killer cells trigger production of β-2-microglobulin to enhance post–bone marrow transplant immunity 86
Granular acute lymphoblastic leukemia in children. "Aieop Cooperative Group for Cytology of Acute Leukemias" 86
Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group 86
Outcome of very late relapse in children with acute lymphoblastic leukemia 85
Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus 85
Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations 85
FGFR1 is a potential therapeutic target in neuroblastoma 84
T lymphocytes against solid malignancies: Winning ways to defeat tumours 84
Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis 84
Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival 84
Characterization of KIR+ NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA-C 83
The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: insights from genomic-wide association studies 83
Natural killer cells in the treatment of high-risk acute leukaemia 83
Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group 83
A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia 83
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma 83
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia 83
Totale 12.877
Categoria #
all - tutte 422.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 422.086


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022133 0 9 5 5 8 6 5 18 7 10 24 36
2022/20231.335 34 47 20 46 27 50 10 38 696 249 68 50
2023/20247.212 213 1.307 421 200 577 1.217 322 292 199 580 692 1.192
2024/202517.567 272 285 1.297 292 668 555 350 433 3.288 1.354 5.052 3.721
2025/202642.277 7.091 1.753 3.717 3.777 6.266 1.810 7.068 1.841 2.335 2.473 1.741 2.405
2026/20275.655 2.732 2.923 0 0 0 0 0 0 0 0 0 0
Totale 74.593